Atomic-scale view of bacterial proteins offers path to new tuberculosis drugs
Friday, February 3, 2017 - 15:41
in Health & Medicine
In studying a cousin of the bacterium that causes tuberculosis, scientists have drawn a molecular map of the target for rifampicin, a common antibiotic. They are now using it in an effort to combat multi-resistant tuberculosis, for which existing treatments don’t work. More »